DEF: Applied Therapeutics Seeks Reverse Stock Split to Regain Nasdaq Compliance at June 9, 2025 Annual Meeting

Applied Therapeutics is asking stockholders to approve a reverse stock split at its annual meeting on June 9, 2025, to regain compliance with Nasdaq listing requirements.

Summary

• Applied Therapeutics, Inc. is holding its Annual Meeting of Stockholders on June 9, 2025, in a virtual-only format.
• Stockholders will vote on several proposals, including the election of one Class III director, ratification of Ernst & Young LLP as the independent accounting firm, and advisory votes on executive compensation.
• A key proposal is to approve an amendment to the company's charter to allow for a reverse stock split, with a ratio between one-for-5 and one-for-40, to be determined by the board.
• The company is seeking authorization to adjourn the meeting if necessary to solicit additional proxies for the reverse stock split proposal.
• The board recommends voting in favor of all proposals, including the reverse stock split.
• The company's stock is currently listed on the Nasdaq Global Market, but it received a deficiency letter for not maintaining a minimum bid price of $1.00 per share.
• As of April 11, 2025, the closing bid price for the company's common stock was $0.32 per share.
• The company has until August 6, 2025, to regain compliance with the Nasdaq listing rules.
• The board believes a higher stock price may help generate investor interest and facilitate future financings.
• The company is exploring various sources of financing, including potential future sales of Common Stock or other securities.
• As of the Record Date, the number of authorized shares of our Common Stock was 250,000,000 shares, which will not be affected by the Reverse Stock Split.

Sentiment

Score: 4

Explanation: The document is primarily factual and procedural, but the need for a reverse stock split suggests underlying financial challenges. The sentiment is neutral to slightly negative.

Positives

• A successful reverse stock split could increase the per-share trading price of the common stock, potentially meeting Nasdaq's listing requirements.
• A higher stock price may attract a broader range of investors, including institutional investors and brokerage firms that avoid lower-priced stocks.
• The board believes a higher stock price may help generate investor interest and facilitate future financings by the Company.

Negatives

• There is no guarantee that the reverse stock split will increase the market price of the common stock.
• The market price of the common stock could decline after the reverse stock split.
• A reverse stock split could reduce the number of outstanding shares, potentially impairing liquidity.
• Some investors may view reverse stock splits negatively.
• If the Company is unable to raise additional capital when needed, through future sales of equity or convertible debt securities or through collaborations, strategic alliances or third-party licensing arrangements, we could be forced to delay, reduce or terminate certain of our development programs or other operations and or may not be able to continue as a going concern.

Risks

• The reverse stock split may not result in a sustained increase in the stock price.
• The company may still fail to meet Nasdaq's minimum bid price requirement even after the reverse stock split.
• A decrease in the number of outstanding shares could reduce liquidity and make the stock less attractive to some investors.
• The board of directors may authorize the issuance of the remaining authorized and unissued shares without further stockholder action for a variety of purposes, except as such shareholder approval may be required in particular cases by our Certificate of Incorporation, applicable law, or the rules of any stock exchange on which our securities may then be listed.
• If we are unable to raise additional capital when needed, through future sales of equity or convertible debt securities or through collaborations, strategic alliances or third-party licensing arrangements, we could be forced to delay, reduce or terminate certain of our development programs or other operations and or may not be able to continue as a going concern.

Future Outlook

The company is exploring various sources of financing, including potential future sales of Common Stock or other securities. There can be no assurance, however, even if the Reverse Stock Split is approved and implemented, that any financing transaction would be undertaken or completed.

Management Comments

• The board of directors believes that the Reverse Stock Split may be necessary to maintain our listing on Nasdaq.
• The board of directors also believes that a higher stock price may help generate investor interest in the Company.
• If the Reverse Stock Split successfully increases the per share price of our Common Stock, the board of directors also believes this increase may increase trading volume in our Common Stock and facilitate future financings by the Company.

Industry Context

Many companies facing similar stock price deficiencies consider reverse stock splits to maintain exchange listings and attract a broader investor base. The success of such strategies varies depending on the company's underlying fundamentals and market conditions.

Comparison to Industry Standards

• Reverse stock splits are a relatively common tool for companies facing delisting from major exchanges due to low share prices.
• Many companies in the biotechnology and pharmaceutical industries, particularly those in the development stage, have used reverse stock splits to maintain compliance with listing requirements.
• Comparable companies that have recently undertaken reverse stock splits include [hypothetical example] Company X and Company Y, both of which were seeking to regain compliance with Nasdaq listing standards.
• The success of these reverse stock splits has varied, with some companies experiencing a sustained increase in share price and others seeing only a temporary effect.

Management Changes

Stakeholder Impact

• Shareholders: The reverse stock split could affect the value and liquidity of their shares.
• Employees: The company's ability to maintain its Nasdaq listing could impact employee morale and stock options.
• Customers: The company's financial stability could affect its ability to invest in research and development and bring new products to market.
• Creditors: The company's ability to raise capital could affect its ability to repay debts.

Next Steps

• Stockholders will vote on the proposals at the Annual Meeting on June 9, 2025.
• The board of directors will determine whether to implement the reverse stock split and at what ratio, if approved by stockholders.
• The company must regain compliance with Nasdaq listing rules by August 6, 2025.

Key Dates

Keywords

reverse stock split, Nasdaq, compliance, stockholders, annual meeting, common stock, listing rules, proxy statement, board of directors, executive compensation